Technology AI, Science and New Things
Elon Musk’s Neuralink is probably the world’s best-known brain-chip company – one of several exploring the potential of brain-computer interfaces (BCI), where implants connect the human brain to an external computer. On Friday, Musk revealed in a podcast that Neuralink had successfully implanted its device into a second patient. But another firm may hold an advantage: graphene, a strong, flexible “wonder material” that is an excellent conductor of electricity. The FT reports that Barcelona-based neurotech firm InBrain has developed a graphene-based BCI that is about to be used in a clinical trial in Manchester. The first step will be testing its safety and signal quality during brain surgery to remove a cancerous tumour. The next step will be clinical trials for patients with Parkinson’s disease.
